Karin E. de Visser

机构：Leiden University Medical Center, The Netherlands Cancer Institute, Oncode Institute · ORCID：0000-0002-0293-868X

发表论文 209 篇 · 总被引 21430 次 · h-index 48

代表论文

• Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial (2024 · Nature Medicine · 被引 72)
• Understanding and reversing mammary tumor-driven reprogramming of myelopoiesis to reduce metastatic spread (2025 · Cancer Cell · 被引 64)
• Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality (2025 · npj Breast Cancer · 被引 21)
• p53 deficient breast cancer cells reprogram preadipocytes toward tumor-protective immunomodulatory cells (2023 · Proceedings of the National Academy of Sciences · 被引 12)
• Single-cell analysis of innate immune cell mechanics: an application to cancer immunology (2024 · Materials Advances · 被引 7)
• Expert opinion on burning questions in cancer myeloid cell biology (2026 · Journal for ImmunoTherapy of Cancer · 被引 1)